Transformable nanoparticles to bypass biological barriers in cancer treatment

Nanomedicine based drug delivery platforms provide an interesting avenue to explore for the future of cancer treatment. Here we discuss the barriers for drug delivery in cancer therapeutics and how nanomaterials have been designed to bypass these blockades through stimuli responsive transformation in the most recent update. Nanomaterials that address the challenges of each step provide a promising solution for new cancer therapeutics.

Automated summary

Nanomedicine-based drug delivery platforms offer a promising avenue for the future of cancer treatment. By addressing barriers and utilizing stimuli-responsive transformations, nanomaterials provide a potential solution for overcoming challenges in drug delivery for cancer therapeutics.